Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

ClinicalTrials.gov ID: NCT00854360

Public ClinicalTrials.gov record NCT00854360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 6:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center, Dose-Range-Finding Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Adult and Adolescent Patients (12 Years and Older) With Seasonal Allergic Rhinitis (SAR)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2, randomized, double-blind, placebo-controlled, parallel-group, 2-week, multi-center, dose-range-finding study in male or female patients (12 years and older) with SAR.

Study identification

NCT ID
NCT00854360
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
487 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2009
Primary completion
Apr 30, 2009
Completion
Apr 30, 2009
Last update posted
May 21, 2012

2009

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Teva Global Respiratory Research Study Site Mission Viejo California 92691
Teva Global Respiratory Research Study Site San Diego California 92120
Teva Global Respiratory Research Study Site San Diego California 92123
Teva Global Respiratory Research Study Site Colorado Springs Colorado 08907
Teva Global Respiratory Research Study Site Denver Colorado 08230
Teva Global Respiratory Research Study Site Gainesville Georgia 030501
Teva Global Respiratory Research Study Site Savannah Georgia 31406
Teva Global Respiratory Research Study Site Indianapolis Indiana 46208
Teva Global Respiratory Research Study Site Overland Park Kansas 66210
Teva Global Respiratory Research Study Site Bethesda Maryland 20814
Teva Global Respiratory Research Study Site St Louis Missouri 63141
Teva Global Respiratory Research Study Site Brick New Jersey 08724
Teva Global Respiratory Research Study Site Raleigh North Carolina 27607
Teva Global Respiratory Research Study Site Medford Oregon 97504
Teva Global Respiratory Research Study Site Portland Oregon 97213
Teva Global Respiratory Research Study Site Blue Bell Pennsylvania 19422
Teva Global Respiratory Research Study Site Pittsburgh Pennsylvania 15241
Teva Global Respiratory Research Study Site Upland Pennsylvania 19013
Teva Global Respiratory Research Study Site Charleston South Carolina 29407
Teva Global Respiratory Research Study Site Austin Texas 78713
Teva Global Respiratory Research Study Site Dallas Texas 75231
Teva Global Respiratory Research Study Site New Braunfels Texas 78130
Teva Global Respiratory Research Study Site San Antonio Texas 78229
Teva Global Respiratory Research Study Site Draper Utah 84020
Teva Global Respiratory Research Study Site Burke Virginia 22015
Teva Global Respiratory Research Study Site Richmond Virginia 23233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00854360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 21, 2012 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00854360 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →